BRIEF-Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing

Reuters

May 06

May 6 (Reuters) - Hepion Pharmaceuticals Inc HEPA.O:

HEPION PHARMACEUTICALS - ON APRIL 30, ENTERED INTO BINDING LOI IN-LICENSES DIAGNOSTIC TESTS FROM NEW DAY DIAGNOSTICS - SEC FILING
HEPION PHARMACEUTICALS INC - TO PAY $525,000 CASH AND $200,000 IN STOCK TO NEW DAY - SEC FILING
HEPION PHARMACEUTICALS INC - AGREES TO PAY UP TO $17.15 MILLION UPON MILESTONE ACHIEVEMENT - SEC FILING
HEPION PHARMACEUTICALS INC - TO PAY ROYALTIES IN UPPER SINGLE TO LOW DOUBLE DIGITS BASED ON NET SALES- SEC FILING

Source text: [ID:n0001641172-25-008761]

Further company coverage: HEPA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2533631361"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533631361\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533631361?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-06 21:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533631361","market":"us","top_or_hot":-1,"title":"BRIEF-Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing </title></head><body><p><span>May 6 (Reuters)</span><span> - </span>Hepion Pharmaceuticals Inc <span>HEPA.O</span>:</p><ul><li><p>HEPION PHARMACEUTICALS - ON APRIL 30, ENTERED INTO BINDING LOI IN-LICENSES DIAGNOSTIC TESTS FROM NEW DAY DIAGNOSTICS - SEC FILING</p></li><li><p>HEPION PHARMACEUTICALS INC - TO PAY $525,000 CASH AND $200,000 IN STOCK TO NEW DAY - SEC FILING</p></li><li><p>HEPION PHARMACEUTICALS INC - AGREES TO PAY UP TO $17.15 MILLION UPON MILESTONE ACHIEVEMENT - SEC FILING</p></li><li><p>HEPION PHARMACEUTICALS INC - TO PAY ROYALTIES IN UPPER SINGLE TO LOW DOUBLE DIGITS BASED ON NET SALES- SEC FILING</p></li></ul><p>Source text: [ID:n0001641172-25-008761]</p><p>Further company coverage: <span>HEPA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-06 21:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing </title></head><body><p><span>May 6 (Reuters)</span><span> - </span>Hepion Pharmaceuticals Inc <span>HEPA.O</span>:</p><ul><li><p>HEPION PHARMACEUTICALS - ON APRIL 30, ENTERED INTO BINDING LOI IN-LICENSES DIAGNOSTIC TESTS FROM NEW DAY DIAGNOSTICS - SEC FILING</p></li><li><p>HEPION PHARMACEUTICALS INC - TO PAY $525,000 CASH AND $200,000 IN STOCK TO NEW DAY - SEC FILING</p></li><li><p>HEPION PHARMACEUTICALS INC - AGREES TO PAY UP TO $17.15 MILLION UPON MILESTONE ACHIEVEMENT - SEC FILING</p></li><li><p>HEPION PHARMACEUTICALS INC - TO PAY ROYALTIES IN UPPER SINGLE TO LOW DOUBLE DIGITS BASED ON NET SALES- SEC FILING</p></li></ul><p>Source text: [ID:n0001641172-25-008761]</p><p>Further company coverage: <span>HEPA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nFWN3RE1VL:1","article_id":"2533631361","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533631361","pubTimestamp":1746538107,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing May 6  - Hepion Pharmaceuticals Inc HEPA.O:HEPION PHARMACEUTICALS - ON APRIL 30, ENTERED INTO BINDING LOI IN-LICENSES DIAGNOSTIC TESTS FROM NEW DAY DIAGNOSTICS - SEC FILINGHEPION PHARMACEUTICALS INC - TO PAY $525,000 CASH AND $200,000 IN STOCK TO NEW DAY - SEC FILINGHEPION PHARMACEUTICALS INC - AGREES TO PAY UP TO $17.15 MILLION UPON MILESTONE ACHIEVEMENT - SEC FILINGHEPION PHARMACEUTICALS INC - TO PAY ROYALTIES IN UPPER SINGLE TO LOW DOUBLE DIGITS BASED ON NET SALES- SEC FILINGSource text: [ID:n0001641172-25-008761]Further company coverage: HEPA.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","HEPA":"Hepion Pharmaceuticals, Inc."},"translate_title":"简介-Hepion Pharma获得New Day Diagnostics的诊断测试许可-SEC备案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HEPA":0.9},"content_text":"BRIEF-Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing May 6 (Reuters) - Hepion Pharmaceuticals Inc HEPA.O:HEPION PHARMACEUTICALS - ON APRIL 30, ENTERED INTO BINDING LOI IN-LICENSES DIAGNOSTIC TESTS FROM NEW DAY DIAGNOSTICS - SEC FILINGHEPION PHARMACEUTICALS INC - TO PAY $525,000 CASH AND $200,000 IN STOCK TO NEW DAY - SEC FILINGHEPION PHARMACEUTICALS INC - AGREES TO PAY UP TO $17.15 MILLION UPON MILESTONE ACHIEVEMENT - SEC FILINGHEPION PHARMACEUTICALS INC - TO PAY ROYALTIES IN UPPER SINGLE TO LOW DOUBLE DIGITS BASED ON NET SALES- SEC FILINGSource text: [ID:n0001641172-25-008761]Further company coverage: HEPA.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}